Synopsis of the 2020 U.S. Department of Veterans Affairs/U.S. Department of defense clinical practice guideline: The diagnosis and management of hypertension in the primary care setting

Mark P. Tschanz*, William C. Cushman, Travis E. Harrell, Dan R. Berlowitz, James L. Sall

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Description: In January 2020, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the diagnosis and management of hypertension in the primary care setting. Methods: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline development effort that included a multidisciplinary panel of practicing clinician stakeholders and conformed to the Institute of Medicine's tenets for trustworthy clinical practice guidelines. The guideline panel developed key questions in collaboration with the ECRI Institute, which systematically searched and evaluated the literature from 15 December 2013 to 25 March 2019 and developed and rated recommendations by using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Recommendations: This synopsis summarizes key features of the guideline in several key areas: the measurement of blood pressure, the definition of hypertension, target treatment goals, and nonpharmacologic and pharmacologic treatment of essential and resistant hypertension.

Original languageEnglish
Pages (from-to)904-913
Number of pages10
JournalAnnals of Internal Medicine
Volume173
Issue number11
DOIs
StatePublished - 1 Dec 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'Synopsis of the 2020 U.S. Department of Veterans Affairs/U.S. Department of defense clinical practice guideline: The diagnosis and management of hypertension in the primary care setting'. Together they form a unique fingerprint.

Cite this